Hostname: page-component-78c5997874-mlc7c Total loading time: 0 Render date: 2024-11-19T04:07:27.307Z Has data issue: false hasContentIssue false
  • English
  • Français

Question & Answer Forum

Published online by Cambridge University Press:  07 November 2014

Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Monograph Supplement
Information
CNS Spectrums , Volume 9 , Issue 4 , April 2004 , pp. 13 - 15
Copyright
Copyright © Cambridge University Press 2004

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Kessler, RC. The impairments caused by social phobia in the general population: implications for intervention. Acta Psychiatr Scand Suppl. 2003;(417):19–27.Google Scholar
2. Foa, EB, Hearst-Ikeda, D, Perry, KJ. Evaluation of a brief cognitive-behavioral program for the prevention of chronic PTSD in recent assault victims. J Consult Clin Psychol. 1995;63(6):948–955.CrossRefGoogle ScholarPubMed
3. Pitman, RK, Sanders, KM, Zusman, RM, et al. Pilot study of secondary prevention of posttraumatic stress disorder with propranolol. Biol Psychiatry. 2002;5;51(2):189–192.Google Scholar
4. Mennin, DS, Fresco, DM, Heimberg, RG, et al. Screening for social anxiety disorder in the clinical setting: using the Liebowitz Social Anxiety Scale. J Anxiety Disord. 2002;16(6):661–673.Google Scholar
5. Benjamin, J, Ben-Zion, IZ, Karbofsky, E, Dannon, P. Double-blind placebo-controlled pilot study of paroxetine for specific phobia. Psychopharmacology (Berl). 2000;149(2):194–196.Google Scholar